Bioteque Valuation
| 4107 Stock | TWD 125.00 0.50 0.40% |
At this time, the firm appears to be fairly valued. Bioteque shows a prevailing Real Value of NT$124.38 per share. The current price of the firm is NT$125.0. Our model approximates the value of Bioteque from analyzing the firm fundamentals such as Return On Equity of 0.18, profit margin of 0.26 %, and Current Valuation of 7.75 B as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Bioteque's price fluctuation is very steady at this time. Calculation of the real value of Bioteque is based on 3 months time horizon. Increasing Bioteque's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bioteque stock is determined by what a typical buyer is willing to pay for full or partial control of Bioteque. Since Bioteque is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bioteque Stock. However, Bioteque's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 125.0 | Real 124.38 | Hype 125.0 | Naive 128.3 |
The intrinsic value of Bioteque's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bioteque's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bioteque helps investors to forecast how Bioteque stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bioteque more accurately as focusing exclusively on Bioteque's fundamentals will not take into account other important factors: Bioteque Total Value Analysis
Bioteque is presently anticipated to have takeover price of 7.75 B with market capitalization of 7.73 B, debt of 105.3 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bioteque fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.75 B | 7.73 B | 105.3 M |
Bioteque Investor Information
About 31.0% of the company shares are owned by insiders or employees . The book value of Bioteque was presently reported as 42.38. The company recorded earning per share (EPS) of 7.34. Bioteque last dividend was issued on the 31st of August 2022. The entity had 103:100 split on the 24th of August 2009. Based on the measurements of operating efficiency obtained from Bioteque's historical financial statements, Bioteque is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.Bioteque Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bioteque has an asset utilization ratio of 47.28 percent. This indicates that the Company is making NT$0.47 for each dollar of assets. An increasing asset utilization means that Bioteque is more efficient with each dollar of assets it utilizes for everyday operations.Bioteque Ownership Allocation
Bioteque holds a total of 69.3 Million outstanding shares. Bioteque retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Bioteque Profitability Analysis
The company reported the revenue of 1.83 B. Net Income was 431.26 M with profit before overhead, payroll, taxes, and interest of 802.87 M.About Bioteque Valuation
Our relative valuation model uses a comparative analysis of Bioteque. We calculate exposure to Bioteque's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bioteque's related companies.8 Steps to conduct Bioteque's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bioteque's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bioteque's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bioteque's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bioteque's revenue streams: Identify Bioteque's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bioteque's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bioteque's growth potential: Evaluate Bioteque's management, business model, and growth potential.
- Determine Bioteque's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bioteque's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Bioteque Stock Analysis
When running Bioteque's price analysis, check to measure Bioteque's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioteque is operating at the current time. Most of Bioteque's value examination focuses on studying past and present price action to predict the probability of Bioteque's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioteque's price. Additionally, you may evaluate how the addition of Bioteque to your portfolios can decrease your overall portfolio volatility.